CB Insights
Technology Market Intelligence
Technology Market Intelligence
Sapience Therapeutics is a preclinical-stage biotechnology company focuses on advancing novel therapeutics for major unmet medical needs, particularly high mortality cancers. The company's drug development program involves translating science into no...Show all
Company (Alive / Active)
Phone: 914-607-6931
500 Mamaroneck Ave
Suite 320
Harrison, 10528
New York, United States
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|---|---|---|
| Celgene | Corporation | Summit, New Jersey, United States | Series A |
| Bristol-Myers Squibb | Corporation | New York, New York, United States | Unattributed |
| Eshelman Ventures | Venture Capital | Wilmington, North Carolina, United States | Series A |
| Columbia University | Academic/University | New York, New York, United States | Series A |
| Healthlink Capital | Other | Series A |
| Name | Firm |
|---|---|
| Login to see details | Edge Therapeutics |
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Atf5 peptide variants and uses thereof | Jan 03, 2019 | Jan 07, 2020 | Patent |
| Cell-penetrating atf5 polypeptides and uses thereof | Feb 17, 2018 | Jun 11, 2019 | Patent |
